II
ONC

IFM Investors’s BeOne Medicines Ltd ONC Stock Holding History

IFM Investors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,729
Closed -$233K – 648
2022
Q3 		$233K Hold
1,729
– – ﹤0.01% 631
2022
Q2 		$280K Hold
1,729
– – ﹤0.01% 630
2022
Q1 		$326K Buy
+1,729
New +$368K 0.01% 633
2020
Q4 		– Sell
-3,330
Closed -$954K – 606
2020
Q3 		$954K Buy
3,330
+356
+12% +$83.7K 0.04% 411
2020
Q2 		$560K Sell
2,974
-29
-1% -$4.72K 0.03% 500
2020
Q1 		$377K Buy
3,003
+346
+13% +$54.1K 0.02% 561
2019
Q4 		$440K Sell
2,657
-269
-9% -$44.7K 0.02% 592
2019
Q3 		$358K Buy
2,926
+977
+50% +$130K 0.01% 598
2019
Q2 		$242K Buy
1,949
+126
+7% +$16K 0.01% 602
2019
Q1 		$241K Hold
1,823
– – 0.02% 584
2018
Q4 		$256K Buy
+1,823
New +$242K 0.02% 571

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IFM Investors's ONC Position: Q4 2022 in Review

IFM Investors sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 1,729 shares — an estimated $233K sold.

IFM Investors first reported a position in ONC in Q4 2018 and held it in 11 quarters. The position peaked at $954K in Q3 2020. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • IFM Investors reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • IFM Investors sold 1,729 BeOne Medicines Ltd shares in Q4 2022, an estimated $233K.
  • IFM Investors first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 11 quarters.
  • IFM Investors's BeOne Medicines Ltd position peaked at $954K in Q3 2020.
  • 212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on IFM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.